Related Experiment Videos
Human stem cell assays in immune-deficient mice
1Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Current Opinion in Hematology
|November 1, 1996
Summary
Mouse models advance hematopoietic system understanding, but human stem cell assays were limited. New methods using SCID mice enable in vivo analysis of human hematopoietic stem cells, including leukemic ones.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunology
Background:
- Mouse models are crucial for understanding hematopoietic system organization and development.
- Human hematopoietic stem cell research was limited by the lack of in vivo repopulation capacity assays.
- Previous limitations hindered the identification and study of human stem cells.
Purpose of the Study:
- To review recent evidence on the utility of in vivo assays for human stem cells.
- To highlight the application of SCID mouse models for studying human hematopoietic stem cells.
- To discuss the assessment of both normal and leukemic human stem cells.
Main Methods:
- Transplantation of normal and leukemic human hematopoietic cells into immune-deficient SCID mice.
- Development of in vivo assays to measure stem cell repopulation capacity.
- Utilizing SCID mouse models as a foundation for human stem cell assays.
Main Results:
- SCID mouse models provide a viable system for human stem cell assays.
- Normal human hematopoietic stem cells can be effectively assayed in this model.
- Leukemic human stem cells also demonstrate assayable characteristics in SCID mice.
Conclusions:
- Immune-deficient SCID mice enable robust in vivo assays for human hematopoietic stem cells.
- These assays are foundational for understanding human stem cell biology and disease.
- The development represents a significant advancement in the study of human hematopoiesis.